Global Imatinib Drugs Market Research Report 2020

Publisher Name :
Date: 26-Feb-2020
No. of pages: 97
Inquire Before Buying

This report focuses on Imatinib Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Imatinib Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- Apotex Inc.

- Novartis

- Sanofi S.A.

- Cipla Inc.

- Mylan Pharms Inc.

- Glenmark Pharmaceuticals Ltd.

- Sun Pharmaceuticals

- Actavis Generics

- Dr. Reddy's Laboratories

- Teva Pharmaceutical Industries Ltd.

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Capsules

- Tablets

Segment by Application

- Hospitals

- Drug Stores

- Other

Global Imatinib Drugs Market Research Report 2020

Table of Contents
1 Imatinib Drugs Market Overview
1.1 Product Overview and Scope of Imatinib Drugs
1.2 Imatinib Drugs Segment by Type
1.2.1 Global Imatinib Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Capsules
1.2.3 Tablets
1.3 Imatinib Drugs Segment by Application
1.3.1 Imatinib Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Other
1.4 Global Imatinib Drugs Market Size Estimates and Forecasts
1.4.1 Global Imatinib Drugs Revenue 2015-2026
1.4.2 Global Imatinib Drugs Sales 2015-2026
1.4.3 Imatinib Drugs Market Size by Region: 2020 Versus 2026
2 Global Imatinib Drugs Market Competition by Manufacturers
2.1 Global Imatinib Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Imatinib Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Imatinib Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Imatinib Drugs Manufacturing Sites, Area Served, Product Type
2.5 Imatinib Drugs Market Competitive Situation and Trends
2.5.1 Imatinib Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Imatinib Drugs Players (Opinion Leaders)
3 Imatinib Drugs Retrospective Market Scenario by Region
3.1 Global Imatinib Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Imatinib Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Imatinib Drugs Market Facts & Figures by Country
3.3.1 North America Imatinib Drugs Sales by Country
3.3.2 North America Imatinib Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Imatinib Drugs Market Facts & Figures by Country
3.4.1 Europe Imatinib Drugs Sales by Country
3.4.2 Europe Imatinib Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Imatinib Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Imatinib Drugs Sales by Region
3.5.2 Asia Pacific Imatinib Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Imatinib Drugs Market Facts & Figures by Country
3.6.1 Latin America Imatinib Drugs Sales by Country
3.6.2 Latin America Imatinib Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Imatinib Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Imatinib Drugs Sales by Country
3.7.2 Middle East and Africa Imatinib Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Imatinib Drugs Historic Market Analysis by Type
4.1 Global Imatinib Drugs Sales Market Share by Type (2015-2020)
4.2 Global Imatinib Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Imatinib Drugs Price Market Share by Type (2015-2020)
4.4 Global Imatinib Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Imatinib Drugs Historic Market Analysis by Application
5.1 Global Imatinib Drugs Sales Market Share by Application (2015-2020)
5.2 Global Imatinib Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Imatinib Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Imatinib Drugs Business
6.1 Apotex Inc.
6.1.1 Corporation Information
6.1.2 Apotex Inc. Description, Business Overview and Total Revenue
6.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Apotex Inc. Products Offered
6.1.5 Apotex Inc. Recent Development
6.2 Novartis
6.2.1 Novartis Imatinib Drugs Production Sites and Area Served
6.2.2 Novartis Description, Business Overview and Total Revenue
6.2.3 Novartis Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis Products Offered
6.2.5 Novartis Recent Development
6.3 Sanofi S.A.
6.3.1 Sanofi S.A. Imatinib Drugs Production Sites and Area Served
6.3.2 Sanofi S.A. Description, Business Overview and Total Revenue
6.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sanofi S.A. Products Offered
6.3.5 Sanofi S.A. Recent Development
6.4 Cipla Inc.
6.4.1 Cipla Inc. Imatinib Drugs Production Sites and Area Served
6.4.2 Cipla Inc. Description, Business Overview and Total Revenue
6.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Cipla Inc. Products Offered
6.4.5 Cipla Inc. Recent Development
6.5 Mylan Pharms Inc.
6.5.1 Mylan Pharms Inc. Imatinib Drugs Production Sites and Area Served
6.5.2 Mylan Pharms Inc. Description, Business Overview and Total Revenue
6.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Mylan Pharms Inc. Products Offered
6.5.5 Mylan Pharms Inc. Recent Development
6.6 Glenmark Pharmaceuticals Ltd.
6.6.1 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Production Sites and Area Served
6.6.2 Glenmark Pharmaceuticals Ltd. Description, Business Overview and Total Revenue
6.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Glenmark Pharmaceuticals Ltd. Products Offered
6.6.5 Glenmark Pharmaceuticals Ltd. Recent Development
6.7 Sun Pharmaceuticals
6.6.1 Sun Pharmaceuticals Imatinib Drugs Production Sites and Area Served
6.6.2 Sun Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sun Pharmaceuticals Products Offered
6.7.5 Sun Pharmaceuticals Recent Development
6.8 Actavis Generics
6.8.1 Actavis Generics Imatinib Drugs Production Sites and Area Served
6.8.2 Actavis Generics Description, Business Overview and Total Revenue
6.8.3 Actavis Generics Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Actavis Generics Products Offered
6.8.5 Actavis Generics Recent Development
6.9 Dr. Reddy's Laboratories
6.9.1 Dr. Reddy's Laboratories Imatinib Drugs Production Sites and Area Served
6.9.2 Dr. Reddy's Laboratories Description, Business Overview and Total Revenue
6.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Dr. Reddy's Laboratories Products Offered
6.9.5 Dr. Reddy's Laboratories Recent Development
6.10 Teva Pharmaceutical Industries Ltd.
6.10.1 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Production Sites and Area Served
6.10.2 Teva Pharmaceutical Industries Ltd. Description, Business Overview and Total Revenue
6.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Teva Pharmaceutical Industries Ltd. Products Offered
6.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
7 Imatinib Drugs Manufacturing Cost Analysis
7.1 Imatinib Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Imatinib Drugs
7.4 Imatinib Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Imatinib Drugs Distributors List
8.3 Imatinib Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Imatinib Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Imatinib Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Imatinib Drugs by Type (2021-2026)
10.2 Imatinib Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Imatinib Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Imatinib Drugs by Application (2021-2026)
10.3 Imatinib Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Imatinib Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Imatinib Drugs by Region (2021-2026)
10.4 North America Imatinib Drugs Estimates and Projections (2021-2026)
10.5 Europe Imatinib Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Imatinib Drugs Estimates and Projections (2021-2026)
10.7 Latin America Imatinib Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Imatinib Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Imatinib Drugs Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Imatinib Drugs Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Imatinib Drugs Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Imatinib Drugs Manufacturers Covered in This Study
Table 5. Global Imatinib Drugs Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Imatinib Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Imatinib Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Imatinib Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Imatinib Drugs Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Imatinib Drugs Sales Sites and Area Served
Table 11. Manufacturers Imatinib Drugs Product Types
Table 12. Global Imatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Imatinib Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imatinib Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Imatinib Drugs Players
Table 16. Global Imatinib Drugs Sales (K MT) by Region (2015-2020)
Table 17. Global Imatinib Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Imatinib Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Imatinib Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 21. North America Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 25. Europe Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Imatinib Drugs Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Imatinib Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Imatinib Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Imatinib Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 33. Latin America Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Imatinib Drugs Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Imatinib Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Imatinib Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Imatinib Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Imatinib Drugs Sales (K MT) by Type (2015-2020)
Table 41. Global Imatinib Drugs Sales Share by Type (2015-2020)
Table 42. Global Imatinib Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Imatinib Drugs Revenue Share by Type (2015-2020)
Table 44. Global Imatinib Drugs Price (USD/MT) by Type (2015-2020)
Table 45. Global Imatinib Drugs Sales (K MT) by Application (2015-2020)
Table 46. Global Imatinib Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Imatinib Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Apotex Inc. Imatinib Drugs Corporation Information
Table 49. Apotex Inc. Description and Business Overview
Table 50. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Apotex Inc. Main Product
Table 52. Apotex Inc. Recent Development
Table 53. Novartis Imatinib Drugs Corporation Information
Table 54. Novartis Corporation Information
Table 55. Novartis Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Novartis Main Product
Table 57. Novartis Recent Development
Table 58. Sanofi S.A. Imatinib Drugs Corporation Information
Table 59. Sanofi S.A. Corporation Information
Table 60. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Sanofi S.A. Main Product
Table 62. Sanofi S.A. Recent Development
Table 63. Cipla Inc. Imatinib Drugs Corporation Information
Table 64. Cipla Inc. Corporation Information
Table 65. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Cipla Inc. Main Product
Table 67. Cipla Inc. Recent Development
Table 68. Mylan Pharms Inc. Imatinib Drugs Corporation Information
Table 69. Mylan Pharms Inc. Corporation Information
Table 70. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Mylan Pharms Inc. Main Product
Table 72. Mylan Pharms Inc. Recent Development
Table 73. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Corporation Information
Table 74. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 75. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Glenmark Pharmaceuticals Ltd. Main Product
Table 77. Glenmark Pharmaceuticals Ltd. Recent Development
Table 78. Sun Pharmaceuticals Imatinib Drugs Corporation Information
Table 79. Sun Pharmaceuticals Corporation Information
Table 80. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Sun Pharmaceuticals Main Product
Table 82. Sun Pharmaceuticals Recent Development
Table 83. Actavis Generics Imatinib Drugs Corporation Information
Table 84. Actavis Generics Corporation Information
Table 85. Actavis Generics Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Actavis Generics Main Product
Table 87. Actavis Generics Recent Development
Table 88. Dr. Reddy's Laboratories Imatinib Drugs Corporation Information
Table 89. Dr. Reddy's Laboratories Corporation Information
Table 90. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Dr. Reddy's Laboratories Main Product
Table 92. Dr. Reddy's Laboratories Recent Development
Table 93. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Corporation Information
Table 94. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 95. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Teva Pharmaceutical Industries Ltd. Main Product
Table 97. Teva Pharmaceutical Industries Ltd. Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Imatinib Drugs Distributors List
Table 101. Imatinib Drugs Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Imatinib Drugs Sales (K MT) Forecast by Type (2021-2026)
Table 106. Global Imatinib Drugs Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Imatinib Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Imatinib Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Imatinib Drugs Sales (K MT) Forecast by Application (2021-2026)
Table 110. Global Imatinib Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Imatinib Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 112. Global Imatinib Drugs Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Imatinib Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Imatinib Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Imatinib Drugs
Figure 2. Global Imatinib Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Capsules Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Imatinib Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospitals
Figure 7. Drug Stores
Figure 8. Other
Figure 9. Global Imatinib Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Imatinib Drugs Sales Capacity (K MT) (2015-2026)
Figure 11. Global Imatinib Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Imatinib Drugs Sales Share by Manufacturers in 2020
Figure 13. Global Imatinib Drugs Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Imatinib Drugs Revenue in 2019
Figure 15. Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Imatinib Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Imatinib Drugs Sales Market Share by Region in 2019
Figure 18. Global Imatinib Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Imatinib Drugs Revenue Market Share by Region in 2019
Figure 20. North America Imatinib Drugs Sales Market Share by Country in 2019
Figure 21. North America Imatinib Drugs Revenue Market Share by Country in 2019
Figure 22. U.S. Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 23. U.S. Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 25. Canada Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Imatinib Drugs Sales Market Share by Country in 2019
Figure 27. Europe Imatinib Drugs Revenue Market Share by Country in 2019
Figure 28. Germany Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 29. Germany Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 31. France Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.K. Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. Italy Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Russia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Imatinib Drugs Sales Market Share by Region in 2019
Figure 39. Asia Pacific Imatinib Drugs Revenue Market Share by Region in 2019
Figure 40. China Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. China Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. Japan Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. South Korea Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. India Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. Australia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Taiwan Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Indonesia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. Thailand Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Malaysia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Philippines Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. Vietnam Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Imatinib Drugs Sales Market Share by Country in 2019
Figure 63. Latin America Imatinib Drugs Revenue Market Share by Country in 2019
Figure 64. Mexico Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. Mexico Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. Brazil Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Argentina Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Imatinib Drugs Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Imatinib Drugs Revenue Market Share by Country in 2019
Figure 72. Turkey Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Turkey Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Saudi Arabia Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Imatinib Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. U.A.E Imatinib Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Imatinib Drugs by Type (2015-2020)
Figure 79. Sales Market Share of Imatinib Drugs by Type in 2019
Figure 80. Revenue Share of Imatinib Drugs by Type (2015-2020)
Figure 81. Revenue Market Share of Imatinib Drugs by Type in 2019
Figure 82. Global Imatinib Drugs Sales Growth by Type (2015-2020) (K MT)
Figure 83. Global Imatinib Drugs Sales Market Share by Application (2015-2020)
Figure 84. Global Imatinib Drugs Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Imatinib Drugs by Application (2015-2020)
Figure 86. Global Revenue Share of Imatinib Drugs by Application in 2020
Figure 87. Apotex Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Cipla Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Mylan Pharms Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Glenmark Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Sun Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Actavis Generics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Imatinib Drugs
Figure 99. Manufacturing Process Analysis of Imatinib Drugs
Figure 100. Imatinib Drugs Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Imatinib Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 105. North America Imatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Imatinib Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Imatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Imatinib Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Imatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Imatinib Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Imatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Imatinib Drugs Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Imatinib Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs